In the research peptide industry, few documents are referenced as frequently—or misunderstood as often—as the Certificate of Analysis, commonly known as the COA. For many researchers, a COA represents assurance: proof of purity, identity, and quality. But after more than a decade in peptide manufacturing, I can say with confidence that a COA is not inherently meaningful on its own.
A COA is only as credible as the data, methodology, instrumentation, and scientific discipline behind it.
The Purpose of a COA: Documentation, Not Decoration
At its core, a Certificate of Analysis is a scientific record. It documents the analytical testing performed on a specific batch of material and reports the results of that testing. In legitimate research settings, the COA exists to support reproducibility, traceability, and experimental confidence.
What a COA is not meant to be is a marketing asset.
Unfortunately, in an increasingly crowded peptide marketplace, COAs are often reduced to visual reassurance—something to display rather than something to scrutinize. Purity percentages are emphasized without context. Analytical methods are listed without explanation. Batch numbers appear, but the underlying data remains inaccessible or unclear.
When this happens, the COA stops serving science and starts serving perception.
Not All Analytical Testing Is Equal
Most COAs in the peptide space reference familiar analytical techniques, particularly:
- High-Performance Liquid Chromatography (HPLC)
- Mass Spectrometry (MS)
These are powerful and widely accepted tools, and when properly executed, they provide meaningful confirmation of peptide purity and molecular identity. However, simply listing HPLC or MS on a COA does not guarantee analytical rigor.
The quality of analytical results depends on multiple factors, including:
- Instrument calibration and maintenance
- Method development and validation
- Sample preparation protocols
- Reference standards used for comparison
- Operator expertise and interpretation
For example, HPLC purity values can vary significantly depending on column selection, mobile phase composition, gradient design, and detection wavelength. Without proper method validation, reported purity percentages may reflect method limitations rather than true sample composition.
Similarly, Mass Spectrometry can confirm molecular weight, but it does not automatically confirm sequence fidelity, purity distribution, or the absence of closely related impurities unless used appropriately and interpreted correctly.
A COA that lacks methodological transparency leaves researchers guessing about what the data truly represents.
Batch-Specific Data vs. Template Certificates
One of the most common red flags in the peptide industry is the reuse of template COAs. These documents may look professional, but they are often detached from the actual batch in question.
A legitimate COA should be:
- Batch-specific
- Generated from actual testing of the final material
- Directly traceable to a unique synthesis and purification run
When certificates are reused, generalized, or pre-generated, they undermine the entire purpose of analytical documentation. Researchers relying on such data may unknowingly introduce variability into their work—variability that can compromise results, waste time, and distort conclusions.
At Hanobi Peptides™, every COA is tied to a specific production batch and generated from real analytical testing. We view batch-specific data not as an inconvenience, but as a fundamental obligation to the research community.
Purity Claims Without Context Are Incomplete
A single purity number—99%, 98%, or otherwise—tells only part of the story.
Purity should be understood in context:
- What impurities are present?
- Are they deletion sequences, truncations, or synthesis byproducts?
- How were they resolved during purification?
- What detection limits apply to the reported method?
In peptide research, two samples with the same reported purity can behave very differently depending on impurity profiles. A COA that reports purity without acknowledging analytical scope or limitations risks oversimplifying complex chemistry.
Scientific integrity requires acknowledging what data can—and cannot—confirm.
The Role of Standards and Best Practices
While research peptide manufacturing is not governed by the same framework as pharmaceutical GMP production, well-established analytical best practices still apply. These include principles drawn from:
- Analytical chemistry standards
- USP and ICH guidance concepts (as reference frameworks)
- Reproducibility and traceability norms in laboratory science
Responsible manufacturers voluntarily align with these principles because they protect the validity of research—not because they are legally mandated.
At Hanobi, we believe that adherence to strong analytical discipline is inseparable from ethical manufacturing. Even when regulations allow flexibility, science demands rigor.
Why This Matters for Researchers
Reproducibility remains one of the greatest challenges in modern research. While experimental design and biological systems play a role, material quality is often overlooked as a source of variability.
When peptide data is unreliable, researchers may:
- Misinterpret results
- Fail to replicate findings
- Attribute inconsistencies to biology rather than materials
A trustworthy COA does not eliminate these risks—but it significantly reduces them. It allows researchers to proceed with confidence that their materials are what they claim to be, characterized with care and transparency.
A COA Reflects a Company’s Values
Ultimately, a Certificate of Analysis is a reflection of the manufacturer behind it.
It reveals:
- Whether data is treated as science or as sales support
- Whether transparency is prioritized over convenience
- Whether long-term trust matters more than short-term appeal
At Hanobi Peptides™, we approach COAs as an extension of our responsibility to science. We do not inflate purity claims, obscure methodology, or treat analytical data as optional. Our certificates are meant to withstand scrutiny, not just satisfy expectation.
Because in research, confidence is not built on certificates alone—it is built on the integrity of the data behind them.